Skip to main content
. 2022 Sep 23;5(9):e2233088. doi: 10.1001/jamanetworkopen.2022.33088

Table 2. Adjusted Association of Each Phthalate Metabolite With High TT Levels and Low SHBG Levels.

Metabolite High TT level Low SHBG level
RR (95% CI)a P value, overall P value RR (95% CI)a P value, overall P value
MCNP
T1 1 [Reference] .44 NA 1 [Reference] .05 NA
T2 0.80 (0.53-1.20) .26 1.35 (0.84-2.16) .21
T3 0.82 (0.56-1.18) .27 1.81 (1.15-2.87) .01b
MCOP
T1 1 [Reference] .66 NA 1 [Reference] .02 NA
T2 0.80 (0.47-1.35) .39 1.79 (1.19-2.71) .007b
T3 0.80 (0.48-1.34) .39 1.96 (1.21-3.16) .008b
MECPP
T1 1 [Reference] .68 NA 1 [Reference] .003b NA
T2 0.85 (0.55-1.30) .44 1.43 (0.94-2.16) .09
T3 1.02 (0.72-1.45) .91 1.84 (1.33-2.54) .001b
MBP
T1 1 [Reference] .08 NA 1 [Reference] .04 NA
T2 0.77 (0.53-1.12) .17 1.75 (1.05-2.93) .03
T3 1.09 (0.74-1.62) .64 1.70 (1.10-2.62) .02
MCPP
T1 1 [Reference] .20 NA 1 [Reference] .03 NA
T2 0.73 (0.49-1.10) .12 1.62 (1.09-2.41) .02
T3 0.72 (0.48-1.07) .10 1.55 (1.04-2.30) .03
MEP
T1 1 [Reference] .69 NA 1 [Reference] <.001b NA
T2 1.17 (0.66-2.09) .57 2.42 (1.65-3.55) <.001b
T3 1.24 (0.75-2.03) .39 2.31 (1.47-3.63) .001b
MEHHP
T1 1 [Reference] .26 NA 1 [Reference] .003b NA
T2 0.71 (0.46-1.08) .11 1.45 (0.92-2.29) .10
T3 0.96 (0.64-1.44) .84 1.94 (1.34-2.81) .001b
MEHP
T1 1 [Reference] .44 NA 1 [Reference] .45 NA
T2 1.20 (0.88-1.64) .24 1.11 (0.75-1.64) .60
T3 1.01 (0.71-1.43) .95 1.23 (0.86-1.77) .24
MiBP
T1 1 [Reference] .60 NA 1 [Reference] .02 NA
T2 0.78 (0.48-1.28) .31 1.78 (1.09-2.91) .02
T3 0.88 (0.61-1.25) .45 1.71 (1.15-2.54) .01b
MNP
T1/T2 1 [Reference] .54 NA 1 [Reference] .42 NA
T3 0.89 (0.61-1.30) .54 1.12 (0.85-1.48) .42
MEOHP
T1 1 [Reference] .31 NA 1 [Reference] .02 NA
T2 0.76 (0.49-1.17) .20 1.57 (1.02-2.43) .04
T3 1.05 (0.72-1.55) .78 1.77 (1.21-2.59) .005b
MBzP
T1 1 [Reference] .82 NA 1 [Reference] .02 NA
T2 0.87 (0.55-1.37) .53 1.44 (0.90-2.29) .13
T3 0.94 (0.64-1.37) .72 1.75 (1.21-2.54) .004b
MHNCH
T1 1 [Reference] .51 NA 1 [Reference] .57 NA
T2 1.41 (0.78-2.54) .25 0.86 (0.51-1.48) .58
T3 0.98 (0.72-1.34) .89 1.18 (0.84-1.67) .34

Abbreviations: MBP, mono-n-butyl phthalate (ng/mL); MBzP, monobenzyl phthalate (ng/mL); MCNP, monocarboxynonyl phthalate (ng/mL); MCOP, monocarboxyoctyl phthalate (ng/mL); MCPP, mono(3-carboxypropyl) phthalate; MECPP, mono(2-ethyl-5-carboxypenty) phthalate; MEHHP, mono(2-ethyl-5-hydroxyhexyl) phthalate; MEHP, mono(2-ethylhexyl) phthalate (ng/mL); MEOHP, mono(2-ethyl-5-oxohexyl) phthalate; MEP, monoethyl phthalate (ng/mL); MHNCH, cyclohexane-1,2-dicarboxylic acid-mono(hydroxy isononyl) ester (ng/mL); MiBP, mono-isobutyl phthalate; MNP, monoisononyl phthalate (ng/mL); NA, not applicable; RR, relative risk; SHBG, sex hormone–binding globulin; T1, first tertile (reference category); T2, second tertile; T3, third tertile; TT, total testosterone.

a

All analyses adjusted for age, race and ethnicity, income, marital status, birth country, educational level, smoking status, alcohol use status, physical activity, and creatinine level.

b

P values are significant at a 1% level of significance after adjusting for multiple comparisons. The overall P value provides an overall association between each phthalate metabolite and each outcome, whereas the P value provides the association of each level of phthalate metabolite with each outcome.